These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 22593543)
1. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity. Twohig JP; Marsden M; Cuff SM; Ferdinand JR; Gallimore AM; Perks WV; Al-Shamkhani A; Humphreys IR; Wang EC FASEB J; 2012 Aug; 26(8):3575-86. PubMed ID: 22593543 [TBL] [Abstract][Full Text] [Related]
2. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease. Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722 [TBL] [Abstract][Full Text] [Related]
3. Death receptor 3 is essential for generating optimal protective CD4⁺ T-cell immunity against Salmonella. Buchan SL; Taraban VY; Slebioda TJ; James S; Cunningham AF; Al-Shamkhani A Eur J Immunol; 2012 Mar; 42(3):580-8. PubMed ID: 22259035 [TBL] [Abstract][Full Text] [Related]
4. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. Jones GW; Stumhofer JS; Foster T; Twohig JP; Hertzog P; Topley N; Williams AS; Hunter CA; Jenkins BJ; Wang EC; Jones SA FASEB J; 2011 Jan; 25(1):409-19. PubMed ID: 20826539 [TBL] [Abstract][Full Text] [Related]
6. Oestrogen-deficiency induces bone loss by modulating CD14 Collins FL; Stone MD; Turton J; McCabe LR; Wang ECY; Williams AS BMC Musculoskelet Disord; 2019 Jul; 20(1):326. PubMed ID: 31299941 [TBL] [Abstract][Full Text] [Related]
7. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Meylan F; Richard AC; Siegel RM Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439 [TBL] [Abstract][Full Text] [Related]
8. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443 [TBL] [Abstract][Full Text] [Related]
9. OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism. Humphreys IR; Loewendorf A; de Trez C; Schneider K; Benedict CA; Munks MW; Ware CF; Croft M J Immunol; 2007 Aug; 179(4):2195-202. PubMed ID: 17675479 [TBL] [Abstract][Full Text] [Related]
10. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss. Collins FL; Williams JO; Bloom AC; Singh RK; Jordan L; Stone MD; McCabe LR; Wang ECY; Williams AS Bone; 2017 Apr; 97():94-104. PubMed ID: 28062298 [TBL] [Abstract][Full Text] [Related]
11. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease. Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS Front Immunol; 2019; 10():1624. PubMed ID: 31379829 [TBL] [Abstract][Full Text] [Related]
12. Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity. Slebioda TJ; Rowley TF; Ferdinand JR; Willoughby JE; Buchan SL; Taraban VY; Al-Shamkhani A Eur J Immunol; 2011 Sep; 41(9):2606-11. PubMed ID: 21688261 [TBL] [Abstract][Full Text] [Related]
13. Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease. Perks WV; Singh RK; Jones GW; Twohig JP; Williams AS; Humphreys IR; Taylor PR; Jones SA; Wang ECY Am J Pathol; 2016 Nov; 186(11):2813-2823. PubMed ID: 27664471 [TBL] [Abstract][Full Text] [Related]
14. TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells. Wang J; Al-Lamki RS; Zhu X; Liu H; Pober JS; Bradley JR BMC Nephrol; 2014 Nov; 15():178. PubMed ID: 25399326 [TBL] [Abstract][Full Text] [Related]
15. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692 [TBL] [Abstract][Full Text] [Related]
16. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931 [TBL] [Abstract][Full Text] [Related]
17. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation. Siakavellas SI; Bamias G Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis. Qin T Mol Vis; 2011; 17():3486-93. PubMed ID: 22219644 [TBL] [Abstract][Full Text] [Related]
19. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity. Valatas V; Kolios G; Bamias G Front Immunol; 2019; 10():583. PubMed ID: 30972074 [TBL] [Abstract][Full Text] [Related]
20. The role of TL1A and DR3 in autoimmune and inflammatory diseases. Aiba Y; Nakamura M Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]